Skip to content
Clinical Trials – home
Ospedale San Raffaele S.r.l.
Sponsor

Ospedale San Raffaele S.r.l.

Italy Via Olgettina 60, 20132 Milan, Italy

About the sponsor

Ospedale San Raffaele S.r.l. is involved in clinical research across several cancer and blood disorder areas, with activity spanning solid tumors and hematologic malignancies. Its studies include chronic lymphocytic leukemia, muscle-invasive bladder cancer, prostate cancer, head and neck cancer, non-small cell lung cancer, and intrahepatic cholangiocarcinoma.

  • Chronic lymphocytic leukemia
  • Prostate cancer and clinically relevant prostate cancer
  • Muscle-invasive bladder cancer
  • Head and neck cancer and non-small cell lung cancer
  • Intrahepatic cholangiocarcinoma

Research activity also includes biomarker-driven approaches, imaging for tumor detection, and perioperative or combination strategies in oncology.

About Specializations

Ospedale San Raffaele S.r.l. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Prostate cancer, Gastric cancer, Pancreatic carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

30 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Propofol
  • Sponsor:Ospedale San Raffaele S.r.l.

Migraine

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Eptinezumab
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Venetoclax
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tacrolimus
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Ospedale San Raffaele S.r.l.
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cangrelor Tetrasodium
  • Sponsor:Ospedale San Raffaele S.r.l.

Multiple sclerosis+1

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ozanimod Hydrochloride
  • Sponsor:Ospedale San Raffaele S.r.l.

HIV infection

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Dolutegravir
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Ospedale San Raffaele S.r.l.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).